Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_assertion type Assertion NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_head.
- NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_assertion description "[The Amplicon class IV with deleted TOP2A had 67% (6/9) cases with recurrence, whereas the other three classes combined had only 12% (3/25) cases (p-value = 0.004) at the time of last follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_provenance.
- NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_assertion evidence source_evidence_literature NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_provenance.
- NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_assertion SIO_000772 18702822 NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_provenance.
- NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_assertion wasDerivedFrom befree-20140225 NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_provenance.
- NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_assertion wasGeneratedBy ECO_0000203 NP257374.RA9Q3-uMcSiR502ZTDkSUquW9iUeJ4MKlG7tnbB25iHd4130_provenance.